Pure antiestrogen RU 58668 - Loaded nanospheres: Morphology, cell activity and toxicity studies

European Journal of Pharmaceutical Sciences

Volumn 21, Issue 2-3, 2004, Pages 361-370

  Ameller, Thibault ^a   Marsaud, Véronique ^a   Legrand, Philippe ^a   Gref, Ruxandra ^a   Renoir, Jack Michel ^a  

^a UNIV PARIS SUD   (France)

Author keywords

Antiestrogen; Cell activity; Morphology; Nanospheres

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; ANTIESTROGEN; ANTINEOPLASTIC AGENT; ESTROGEN; MACROGOL; NANOPARTICLE; POLYCAPROLACTONE; POLYGLACTIN; POLYLACTIDE; POLYMER;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADABILITY; BREAST CANCER; CANCER CELL; CELL ACTIVITY; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG ADSORPTION; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; EXTRAVASATION; FEMALE; FREEZE FRACTURE; HORMONE INHIBITION; HUMAN; HUMAN CELL; MOLECULAR MODEL; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SLOW RELEASE FORMULATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

EID: 0742321962     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2003.11.002     Document Type: Article

References (27)

1. Allen T.M., Brandeis E., Hansen C.B., Kao G.Y., Zalipsky S. A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells. Biochim. Biophys. Acta. 1237:1995;99-108.
2. Ameller T., Marsaud V., Legrand P., Gref R., Barratt G., Renoir J.M. Polyester-poly(ethylene glycol) nanoparticles loaded with the pure antiestrogen RU 58668: physico-chemical and opsonisation properties. Pharm. Res. 20:2003a;1063-1070.
3. Ameller T., Marsaud V., Legrand P., Gref R., Renoir J.M. In vitro and in vivo biological evaluation of long circulating biodegradable drug carriers loaded with the pure anti-estrogen RU 58668. Int. J. Cancer. 106:2003b;446-454.
4. Boudad H., Legrand P., Appel M., Coconnier M., Ponchel G. Formulation and cytotoxicity of combined cyclodextrin poly(alkylcyanoacrylate) nanoparticles on Caco-2 cells monolayers intended for oral administration of saquinavir. S.T.P. Pharma. 11:2001;369-375.
5. Dahl R., Staehelin L.A. High-pressure freezing for the preservation of biological structure: theory and practice. J. Electron. Microsc. Technol. 13:1989;165-174.
6. Fessi H., Puisieux F., Devissaguet J., Ammoury N., Benita S. Nanocapsules formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:1989;r1-r4.
7. Gabizon A., Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6949-6953.
8. Gagne D., Balaguer P., Demirpence E., Chabret C., Trousse F., Nicolas J.C., Pons M. Stable luciferase transfected cells for studying steroid receptor biological activity. J. Biolumin. Chemilumin. 9:1994;201-209.
9. Gref R., Domb A., Quellec P., Blunk T., Müller R.H., Verbavatz J.M., Langer R. The controlled intravenous delivery of drugs using PEG-grafted sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 16:1995;215-233.
10. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1603.
11. Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., Jain R.K. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc. Natl. Acad. Sci. U.S.A. 95:1998;4607-4612.
12. Labhasetwar V. Nanoparticles for drug delivery. Pharm. News. 4:1997;28-31.
13. Leroueil-Le Verger M., Fluckiger L., Kim Y.I., Hoffman M., Maincent P. Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur. J. Pharm. Biopharm. 46:1998;137-143.
14. Li Y., Pei Y., Zhang X., Gu Z., Zhou Z., Yuan W., Zhou J., Zhu J., Gao X. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J. Control Release. 71:2001;203-211.
15. MacGregor J.I., Jordan V.C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50:1998;151-196.
16. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53:2001;283-318.
17. Moor, H., 1987. In: Steinbrecht, R.A., Zierhold, K. (Eds.), Cryotechniques in Biological Electron Microscopy. Springer, Berlin.
18. Mosmann T. Rapid calorimetric assay for cellular growth and survival: application of proliferation and cytotoxicity assay. J. Immunol. Methods. 65:1983;55-63.
19. Müller R.H., Mehnert W., Lucks J.S., Schwartz C., Mühlen A., Weyhers H., Freitas C., Ruhl D. Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41:1995;62-69.
20. Polakovic M., Gorner T., Gref R., Dellacherie E. Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. J. Controlled Release. 60:1999;169-177.
21. Quellec P., Gref R., Perrin L., Dellacherie E., Sommer F., Verbavatz J.M., Alonso M.J. Protein encapsulation within polyethylene glycol-grafted nanospheres. I. Physicochemical characterization. J. Biomed. Mater. Res. 42:1998;45-54.
22. Suchira S.S., Kevin G., Dennis H.R. Preparation and characterization of biodegradable poly(DL-lactic acid) gentamicin delivery systems. Int. J. Pharm. 78:1992;165-174.
23. Van de Velde P., Nique F., Bouchoux F., Bremaud J., Hameau M.C., Lucas D., Moratille C., Viet S., Philibert D., Teutsch G. RU 58,668, a new pure antiestrogen inducing a regression of human mammary carcinoma implanted in nude mice. J. Steroid. Biochem. Mol. Biol. 48:1994;187-196.
24. Van de Velde P., Nique F., Bremaud J., Hameau M.C., Philibert D., Teutsch G. Exploration of the therapeutic potential of the antiestrogen RU 58668 in breast cancer treatment. Ann. N.Y. Acad. Sci. 761:1995;164-175.
25. Van de Velde P., Nique F., Planchon P., Prevost G., Bremaud J., Hameau M.C., Magnien V., Philibert D., Teutsch G. RU 58668: further in vitro and in vivo pharmacological data related to its antitumoral activity. J. Steroid Biochem. Mol. Biol. 59:1996;449-457.
26. Von Burkersroda F., Schedl L., Gopferich A. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials. 23:2002;4221-4231.
27. Zange R., Kissel T. Comparative in vitro biocompatibility testing of polycyanoacrylates and poly(D,L-lactide-co-glycolide) using different mouse fibroblast (L929) biocompatibility test models. Eur. J. Pharm. Biopharm. 44:1997;149-157.